Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79,794,643
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
12,700,475
-
Shares change
-
+421,519
-
Total reported value, excl. options
-
$54,741,949
-
Value change
-
+$1,963,390
-
Put/Call ratio
-
67%
-
Number of buys
-
33
-
Number of sells
-
-21
-
Price
-
$4.31
Significant Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q4 2019
76 filings reported holding NAGE - Niagen Bioscience, Inc. - Common Stock as of Q4 2019.
Niagen Bioscience, Inc. - Common Stock (NAGE) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12,700,475 shares
of 79,794,643 outstanding shares and own 16% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2,472,096 shares), VANGUARD GROUP INC (2,088,810 shares), ICONIQ Capital, LLC (1,707,317 shares), Tieton Capital Management, LLC (1,547,127 shares), STATE STREET CORP (682,298 shares), Uniplan Investment Counsel, Inc. (675,104 shares), GEODE CAPITAL MANAGEMENT, LLC (498,933 shares), NORTHERN TRUST CORP (464,513 shares), Sycale Advisors (NY) LLC (315,025 shares), and Mercator Fund (Cayman Master) LP (315,025 shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.